Figure 2.
Managing immunosuppressants in the setting of nirmatrelvir and ritonavir use. JAK, Janus kinase; PRN, pro re nata (as needed).

Managing immunosuppressants in the setting of nirmatrelvir and ritonavir use. JAK, Janus kinase; PRN, pro re nata (as needed).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal